The incidence of gallstone disease in patients with cirrhosis is greater th
an that in healthy patients. Previous surgical literature reported greater
morbidity and mortality in patients with cirrhosis with both open and lapar
oscopic cholecystectomy (LC). We compared our recent experience with LC in
patients with cirrhosis and controls. A retrospective review was performed
using the search terms, "cirrhosis" and "laparoscopic cholecystectomy." For
ty-eight patients with cirrhosis were identified and randomly matched with
healthy controls by age and sex. Four controls were assigned per patient wi
th cirrhosis. Outcomes assessed included mortality, duration of surgery, le
ngth of hospital stay, blood transfusion requirement, postoperative complic
ations, and need for conversion to open cholecystectomy. Forty-eight patien
ts with cirrhosis and 187 healthy controls underwent LC. Child-Pugh classif
ication of severity of liver disease was as follows: Child's class A, 38 of
48 patients; Child's class B, 10 of 48 patients; and Child's class C, 0 of
48 patients. Patients with cirrhosis had statistically significantly lower
albumin levels (P = .0001) and prolonged prothrombin times (P = .05), Aver
age duration of surgery for patients with cirrhosis was 1.71 versus 1.57 ho
urs (P = .57) for controls. Average length of hospital stay for patients wi
th cirrhosis was 6.47 versus 4.77 days (P = .152) for controls, Average num
ber of units of blood transfused in patients with cirrhosis was 0.156 versu
s 0.0 units (P = .025) in controls. Complications occurred in 6 of 48 patie
nts with cirrhosis (12.5%) and 8 of 187 controls (4.2%; P < .05). No child'
s class C patient underwent LC. Four patients with cirrhosis (8.3%) and no
controls were converted to open cholecystectomy. No postoperative infection
s were noted. There was no mortality in either group. LC in patients with C
hild's class A and B cirrhosis is reasonably safe and shows no increase in
morbidity or mortality or worsening of outcome. Further studies are require
d to evaluate the management of acute gallbladder disease in Child's class
C patients.